Drugmakers released cancer data at ASCO, with AstraZeneca taking center stage. A report found that digital physical therapy tools provide clinical benefits.
More than 5,000 research abstracts were presented or published at ASCO. They included data on existing drugs, experimental treatments, AI tools and ideas for improving patient care.by 84% compared to placebo in patients with stage three non-small cell lung cancer caused by mutations in a gene called EGFR, according to new late-stage trial results.
During an event at ASCO, Eli Lilly gave investors a glimpse at both late-stage and early-stage experimental drugs in its oncology pipeline, along with updates on its existing cancer treatments, including Verzenio and Jaypirca.
PHTI said around one in three people in the U.S. have musculoskeletal conditions, and they account for almost 10% of medical spending in the country, according to The organization split the solutions into three categories: physical therapist-guided solutions , app-based exercise therapy with limited participation from physical therapists and remote therapeutic monitoring solutions, which are designed to supplement in-person care .
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins bigDrugmakers released cancer data at ASCO, with AstraZeneca taking center stage. A report found that digital physical therapy tools provide clinical benefits.
Read more »
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceCNBC will be on the ground at the ASCO annual meeting in Chicago. Meanwhile, Epic released a free tool set to help health systems evaluate AI models.
Read more »
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Read more »
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Read more »
Bucs' Chris Godwin is healthy and eager for new role as he returns to slotChris Godwin has been a steady playmaker despite some recent injuries. Healthy and still just 28, the Bucs receiver could step into a larger role in the slot.
Read more »
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey saysA wide swath of Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind’s new AI model can predict the structure of…
Read more »